Skip to content

Effective substance basis and mechanism of action of Yifei moxibustion in the treatment of COPD

Effective substance basis and mechanism of action of Yifei moxibustion in the treatment of COPD

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074865
Enrollment
Unknown
Registered
2023-08-18
Start date
2023-08-18
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease

Interventions

YFM group:Health education +Basic treatment of western medicine + Yifei moxibustion
Control group:Health education + Basic treatment of western medicine

Sponsors

The First Affiliated Hospital of Henan University of CM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: ?Patients who meet the diagnosis of stable stage of chronic obstructive pulmonary disease; ? Age 40~80 years old; ?Patients with lung qi deficiency, lung spleen qi deficiency, or lung kidney qi deficiency; ?Not participating in clinical studies of other interventions within 1 month prior to enrolment; ?Able to tolerate YFM therapy; ?Voluntary acceptance of the treatment and signing of the informed consent form.

Exclusion criteria

Exclusion criteria: ?Pregnant and lactating women; ? Patients with delirium, dementia, and various psychiatric disorders; ? Combined severe cardiac insufficiency, liver and kidney diseases; ? Combined active tuberculosis, diffuse panfine bronchitis, pneumothorax, pleural effusion, pulmonary embolism, tumour; ?Those who are known to be allergic to the drug composition of YFM.

Design outcomes

Primary

MeasureTime frame
Number of acute exacerbations;

Secondary

MeasureTime frame
Clinical symptoms and signs;mMRC;6MWD;CAT;mESQ-COPD;SF-36;mCOPD-PRO;Number of colds;Biological indicators;Biochemical indicators;Pulmonary function;

Countries

China

Contacts

Public ContactLi Suyun

The First Affiliated Hospital of Henan University of CM

lisuyun2000@126.com+86 139 3841 5502

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026